Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡